- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rubicon Research Ltd (RUBI)
Track today's live Rubicon Research (RUBI) share price, performance and key data on this page with our current NSE:RUBI stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Rubicon Research share price on the NSE exchange. Use the dropdown to switch exchange for the RUBI share price, head to our technical summary section, which provides analysis on Rubicon Research share price buy/sell indicators using real-time data (or discuss the Rubicon Research (RUBI) stock price today with other investors in the Rubicon Research NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:RUBI share price (ISIN: INE506V01022) to enhance your trading decisions with our free investment tools and resources.
What Is the Rubicon Research Ltd Share Price Today?
The Rubicon Research share price today is 1,307.00.
What Is the Stock Symbol for Rubicon Research Ltd
The stock symbol (or 'ticker') for Rubicon Research Ltd is "RUBI."
What Stock Exchange Does Rubicon Research Ltd Trade On?
Rubicon Research Ltd is listed and trades on the NSE stock exchange.
Is Rubicon Research Ltd a Good Stock to Buy?
Determining whether Rubicon Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:RUBI share price (ISIN: INE506V01022) to enhance your trading decisions with our free investment tools and resources.
What Is the Rubicon Research Ltd Share Price Today?
The Rubicon Research share price today is 1,307.00.
What Is the Stock Symbol for Rubicon Research Ltd
The stock symbol (or 'ticker') for Rubicon Research Ltd is "RUBI."
What Stock Exchange Does Rubicon Research Ltd Trade On?
Rubicon Research Ltd is listed and trades on the NSE stock exchange.
Is Rubicon Research Ltd a Good Stock to Buy?
Determining whether Rubicon Research (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
1,307.00
-67.20(-4.89%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,286.30
1,385.10
52 wk Range
485.00
1,468.70
RUBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,286.301,385.10
52 wk Range
485.001,468.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
RUBI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1,175.00
Downside
-10.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,175.00
(-10.10% Downside)
Earnings
Latest Release
03/06/2026
EPS / Forecast
4.70 / 4.10
Revenue / Forecast
5.14B / 4.93B
Compare RUBI to Peers and Sector
Metrics to compare | RUBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRUBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 87.3x | 34.7x | −0.4x | |
PEG Ratio | 1.14 | 0.71 | 0.00 | |
Price/Book | 16.7x | 2.5x | 2.6x | |
Price / LTM Sales | 12.3x | 3.8x | 3.1x | |
Upside (Analyst Target) | −10.1% | −0.4% | 48.8% | |
Fair Value Upside | Unlock | −1.6% | 6.3% | Unlock |
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Rubicon Research (NSE: RUBI) Share Price Today?
The Rubicon Research stock price today is 1,307.00 INR.
What Stock Exchange Does Rubicon Research (RUBI) Trade On?
Rubicon Research is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Rubicon Research?
The stock symbol (also called a 'ticker') for Rubicon Research is "RUBI."
What Is the Current Rubicon Research Market Capitalisation?
As of today, Rubicon Research (NSE: RUBI) market cap is 215.33B INR.
What Is Rubicon Research's (RUBI) Earnings Per Share (TTM)?
The Rubicon Research EPS is currently 15.31 (Trailing Twelve Months).
When Is the Next Rubicon Research Earnings Date?
Rubicon Research's next earnings report will be released on 02/09/2026.
Is RUBI a Buy or Sell From a Technical Analyst Perspective?
Based on today's Rubicon Research moving averages and other technical indicators, the daily buy/sell signal for RUBI stock is Sell.
How Many Times Has Rubicon Research Stock Split?
Rubicon Research has split 0 times. (See the RUBI stock split history page for full effective split date and price information.)
How Many Employees Does Rubicon Research Have?
Rubicon Research has 903 employees, based on their latest Companies House report.
What is the current trading status of Rubicon Research (NSE: RUBI)?
As of 05/07/2026, Rubicon Research (RUBI) is trading at a share price of 1,307.00 INR, with a previous close of 1,374.20 INR. The stock has fluctuated within a day range of 1,286.30 INR to 1,385.10 INR, while its 52-week range spans from 485.00 INR to 1,468.70 INR.
What Is Rubicon Research (RUBI) Price Target According to Analysts?
The average 12-month price target for Rubicon Research is 1,175.00 INR, with a high estimate of 1190 INR and a low estimate of 1160 INR. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -10.10% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.